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Abstract
Although Leishmania parasites have been shown to modulate their host cell’s responses to multiple stimuli, there is limited
evidence that parasite molecules are released into infected cells. In this study, we present an implementation of the change
mediated antigen technology (CMAT) to identify parasite molecules that are preferentially expressed in infected cells. Sera
from mice immunized with cell lysates prepared from L. donovani or L. pifanoi-infected macrophages were adsorbed with
lysates of axenically grown amastigotes of L. donovani or L. pifanoi, respectively, as well as uninfected macrophages. The
sera were then used to screen inducible parasite expression libraries constructed with genomic DNA. Eleven clones from the
L. pifanoi and the L. donovani screen were selected to evaluate the characteristics of the molecules identified by this
approach. The CMAT screen identified genes whose homologs encode molecules with unknown function as well as genes
that had previously been shown to be preferentially expressed in the amastigote form of the parasite. In addition a variant
of Tryparedoxin peroxidase that is preferentially expressed within infected cells was identified. Antisera that were then
raised to recombinant products of the clones were used to validate that the endogenous molecules are preferentially
expressed in infected cells. Evaluation of the distribution of the endogenous molecules in infected cells showed that some
of these molecules are secreted into parasitophorous vacuoles (PVs) and that they then traffic out of PVs in vesicles with
distinct morphologies. This study is a proof of concept study that the CMAT approach can be applied to identify putative
Leishmania parasite effectors molecules that are preferentially expressed in infected cells. In addition we provide evidence
that Leishmania molecules traffic out of the PV into the host cell cytosol and nucleus.
Citation: Kima PE, Bonilla JA, Cho E, Ndjamen B, Canton J, et al. (2010) Identification of Leishmania Proteins Preferentially Released in Infected Cells Using Change
Mediated Antigen Technology (CMAT). PLoS Negl Trop Dis 4(10): e842. doi:10.1371/journal.pntd.0000842
Editor: Diane McMahon-Pratt, Yale University, United States of America
Received June 16, 2009; Accepted September 8, 2010; Published October 5, 2010
Copyright:  2010 Kima et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported in part by a grant (R01 AI048739) to PEK. The funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: pkima@ufl.edu
Introduction
Leishmaniasis is a disease that affects over 12 million people in
approximately 88 countries. It manifests as varying types of
cutaneous lesions, mucocutaneous lesions or visceral disease; the
type of disease presentation is dependent on both the parasite
species and characteristics of the host that are not completely
defined. Parasite lesions are sites of inflammation where
Leishmania-infected cells are exposed to a range of potential
leishmanicidal activities. It is therefore no surprise that Leishmania
infected cells exhibit altered responses including refractoriness to
IFN-gamma activation [1,2], inhibition of LPS induced signaling
[3], altered calcium mobilization [4] and non responsiveness to
inducers of cell death [5]. Together, these responses enable the
parasite to persist within the host cell.
Studies on other intracellular microorganisms have shown that
within the intracellular milieu, intracellular organisms elaborate
molecules that target host cell functions. For example, in the
apicomplexan organism Toxoplasma gondii, which resides in PVs
that are mostly of parasite origin, molecules from secretory
organelles have been shown to traffic beyond the pathogen
vacuole and target activities in the host cell cytosol and nucleus
[6]. Similarly, prokaryotic pathogens such as Salmonella and
Legionella synthesize effector molecules in the intracellular milieu
that subsequently gain access to the host cell cytosol via type III
and type IV secretion apparatus, respectively [7,8]. Importantly,
these effector molecules are not expressed by organisms that are
grown in liquid broth. Presuming that Leishmania species also
elaborate molecules that target host cell processes, there is
currently limited knowledge of the identity of such molecules
and the conditions under which these molecules are synthesized
and released into the infected cell. However, there is considerable
evidence that Leishmania parasites also differentially express
molecules in response to changes in their environment. For
example, promastigote stage-specific molecules such as GP46,
GP63 and lipophosphoglycan are rapidly turned off once parasites
are internalized into macrophages or when promastigote forms are
incubated in specialized media and growth conditions more suited
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transporter was shown to be preferentially induced in parasites
that reside within PVs only after several days of infection [12].
Following from these observations, it is plausible to expect that, as
compared to axenically cultured organisms, parasites that grow
within infected cells or inside infected hosts most likely elaborate
new (or antigenically modified) molecules that permit them to
function in the intracellular environment. It is to be expected
though that the differential expression of such molecules would
depend, in large part, on the actual details of parasite culture.
To identify parasite molecules that are preferentially expressed
in infected cells, we elected to implement the change mediated
antigen technology (CMAT), which is a variation of the in vivo
induced antigen technology (IVIAT). Both of these screens are
immunological screens that take advantage of the fact that
antibodies can be raised to new molecules which are expressed
by organisms that sense changes in their environment when they
enter infected hosts as compared to organisms grown under
standard laboratory culture [13,14]. The immune serum that is
elaborated in response to pathogens within infected hosts will
include antibodies that are reactive to parasite structural molecules
and housekeeping molecules that perform vital metabolic functions
in the parasite. Incubation of this immune serum with axenic
cultured organisms should result in strong reactivity of the
antiserum with many of the latter parasite molecules. In the
CMAT and IVIAT screens, immune serum is incubated with
lysates of the pathogen grown under standard laboratory
conditions to deplete the serum of antibodies that are reactive to
parasite structural and housekeeping molecules. The depleted
serum becomes enriched for immunoglobulins that are reactive to
molecules preferentially expressed within the infected host. To
date, CMAT and IVIAT have identified over 1000 in vivo induced
antigens in infections including Bacillus anthracis, Tannerella forsythia,
Mycobacterium tuberculosis, Salmonella enterica serovar Typhi, group A
Streptococcus, E. coli O157:H7, Vibrio vulnificus and V. cholera, among
others [15–21]. These newly identified antigens include new
virulence factors in these organisms as well as pathogen proteins
previously shown to be preferentially expressed in the infected
host.
In the study presented here, serum reactive to infected cells was
raised by immunization of mice with lysates of cells infected with
L. pifanoi or L. donovani parasites. After adsorbing this serum
extensively against axenic amastigote forms to remove antibodies
that are reactive to molecules expressed by axenically cultured
organisms, the adsorbed serum was used to screen inducible
parasite genomic expression libraries. A few of the endogenous
genes identified by the CMAT screen were analyzed for their time-
course of expression and their distribution in infected cells.
Evidence is presented that Leishmania parasite molecules identified
by CMAT traffic outside the PV and are therefore putative
candidate effectors.
Materials and Methods
Parasites and culture conditions
Leishmania pifanoi promastigotes (MHOM/VE/57/LL1) ob-
tained from the ATCC were grown in Schneiders medium
supplemented with 10% fetal calf serum and 10 mg/ml gentamicin
at 23uC. L. donovani strain 1S-CL2D from Sudan, World Health
Organization (WHO) designation: (MHOM/SD/62/1S-CL2D)
was obtained from Dr. Debrabant (USDA, MD). Promastigotes of
this parasite strain were grown in Medium-199 (with Hank’s salts,
Gibco Invitrogen Corp.) supplemented to a final concentration of
2 mM L-glutamine, 100 mM adenosine, 23 mM folic acid, 100 IU
and 100 mg/ml each of penicillin G and streptomycin, respective-
ly, 16BME vitamin mix, 25 mM Hepes, and 10% (v/v) heat-
inactivated (45 min at 56uC) fetal bovine serum, adjusted with 1 N
HCl to pH 6.8 at 26uC. Generation of amastigotes forms was
carried out as described [22]. L. donovani axenic amastigotes
parasites were maintained in RPMI-1640/MES/pH 5.5 medium
at 37uC in a humidified atmosphere containing 5–7% CO2 in air.
L. pifanoi amastigotes were maintained in the amastigote medium
above at 34uC. The RAW 264.7 murine macrophage cell line was
cultured in RPMI supplemented with 10% fetal calf serum and
100 units Penicillin/Streptomycin at 37uC under a 5% CO2
atmosphere.
Construction of inducible Leishmania genomic DNA
expression libraries
Genomic DNA of L. donovani and L. pifanoi parasites was
prepared using the TELT method [23]. The genomic DNA was
digested with Sau3A and 0.5–2.0 kb fragments were size selected.
BL21(DE3)-based inducible expression libraries were constructed
with L. pifanoi and L. donovani fragments in pET30abc using
techniques previously described [13,24].
Generation of antiserum and adsorbtion of serum to
Leishmania amastigotes grown axenically
Macrophages infected for 24 H with amastigotes of L. donovani
or L. pifanoi were lysed in lysis buffer (25 mM HEPES, 150 mM
NaCl, 1% Triton X-100, 1x protease inhibitor pill (1 pill/10 mL),
20 ul/mL Phosphatase Inhibitor Cocktail 1, 20 ul/mL Phospha-
tase Inhibitor Cocktail 2 (Sigma), 50 uM NaVO4). 100 ug of lysate
per mouse was emulsified in an equal volume of titermax gold
adjuvant (Sigma Aldrich). BALB/c mice were immunized and
boosted twice. Sera from 4 mice was combined and used in
adsorptions. Antibodies reactive with antigens expressed by
axenically grown parasites were removed by 4 successive
incubations of sera with whole parasites (5610
8 parasites per
adsorption) in PBS supplemented with 1% bovine serum albumin
(BSA) and 0.05% sodium azide as described earlier [24]. Sera were
Author Summary
Leishmania are intracellular parasites that reside within
parasitophorous vacuoles (PV) in phagocytes. From within
these compartments parasites control the host cell’s
responses to multiple stimuli. There is limited knowledge
of the molecules that Leishmania parasites elaborate in the
host cell to target processes therein. Furthermore, the
mechanism by which such molecules would access their
targets beyond the PV is not known. In the study
presented here, we implemented the change mediated
antigen technology (CMAT) to identify parasite molecules
that are preferentially expressed inside infected cells. The
approach was based on the reasoning that parasites
express ‘new’ or antigenically modified molecules in the
intracellular environment; therefore antiserum that is
reactive to infected cells would contain immunoglobulins
that are specific to these ‘new’ molecules. After adsorption
of the antiserum with axenically cultured parasites, the
antiserum was used to screen a parasite genomic
expression library to identify genes encoding the mole-
cules that are preferentially expressed in infected cells. We
present for the first time evidence that some of these
CMAT molecules accumulate in the PV and then traffic into
the host cell in vesicles of distinct morphologies.
Furthermore, several of these parasite molecules become
localized in discrete compartments within the host cell.
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parasites) and heat treated parasites that had been charged onto
microspheres (polystyrene microspheres, Bangs Labs, Fishers IN).
An additional adsorption was performed with RAW 264.7 lysates
charged onto microspheres. Aliquots were saved after each
adsorption
ELISA
Reactivity of adsorbed sera was determined by incubation of
serially diluted sera in 96 well plates (Nalge Nunc International,
Rochester, NY), that were pre-coated with lysates from axenic
parasites, infected cells or uninfected cells. A Goat anti-mouse-
HRP secondary antibody was applied. Plates were developed using
HRP substrate solutions (BD Biosciences, San Jose, CA) and plates
were read at 450 nm on a Powerwave 200 spectrophotometer
(Bio-Tek, Winooski, VT).
Primary screening of the protein expression library,
identification of inserts
The genomic expression library was grown on LB medium
containing kanamycin (50 mg ml
21) for 12–14 H at 37uCt o
generate plates containing approximately 200–500 colonies. Each
plate was replicated using nitrocellulose disks that were then
placed onto a LB plate containing kanamycin and IPTG (1 mM)
and incubated for 5 H at 37uC to induce expression of cloned
open reading frames (ORFs). The colonies were exposed to
chloroform vapors for 20 min, then overlaid with nitrocellulose
membranes. The membranes were incubated in PBS, pH 7.2,
containing 0.5% Tween-20 (PBS-Tween) and 5% non-fat skim-
milk. They were reacted with the adsorbed sera at a 1:300 dilution
in PBS-Tween for 1 H, then with peroxidase-conjugated goat anti-
mouse immunoglobulin at a 1:3000 dilution for 1 H. Reactive
clones were detected by enhanced chemiluminescence (ECL kit,
Amersham Pharmacia) and exposure to Hyperfilm (Amersham
Pharmacia).
To confirm the immunoreactivity of the clones identified above,
several colonies from the master plate in the apparent vicinity of
the signal were streaked for single colony isolation onto LB plates.
After overnight incubation, three single colonies isolated from each
original colony were resuspended in fresh liquid LB medium
containing kanamycin. Aliquots were blotted onto solid LB
medium containing kanamycin and IPTG. Following the
induction of recombinant protein expression, the blotted cells
were lysed and re-screened using the same procedures as in the
first round of screening. Two negative controls were included on
each plate: pET30b/BL21(DE3) with no cloned insert, and a
random clone that contained an insert but was non-reactive with
sera.
PCR amplification
PCR primers to amplify the gene transcripts of the antigens
identified with CMAT were designed using the sequence in the
clones or the sequence of the closest homolog available in the
sequence database (www.genedb.org) as well as the 59 splice
leader. For example, for the IVI-59, the L. infantum ortholog
(LinJ31_V3.1500) was used to design primers to amplify a transcript
fragment corresponding to nucleotide positions +376 to +2113 of
the L. infantum sequence. The PCR primers used were FB535 59-
CCATGGACCTGCCCACCGTCACATTC-39 and FB536 59-
AGCTTGCCACGCTGCCACCTCTTTGAG-39. The PCR pro-
duct was electrophoresed in a 1% agarose gel and a fragment at the
expected size location (1771 bp) was observed. The PCR fragment
was excised from the gel, purified using a gel extraction kit (Qiagen)
and cloned into a pET30 expression vector (Novagen) using
restriction sites incorporated into the primers.
Western Blot analysis
RAW 264.7 macrophages plated in 100 mm dishes were
infected with L. donovani or L. pifanoi promastigotes. At various
times, parasites were removed, cell monolayers washed twice with
PBS and the infected macrophages were lysed directly in the plate
with lysis buffer (25 mM HEPES, 150 mM NaCl, 1% Triton X-
100, 1x protease inhibitor pill (1 pill/10 mL) (Roche Applied
Science, Indianapolis, IN), 20 ul/mL Phosphatase Inhibitor
Cocktail 1 (Sigma-Aldrich, St. Louis, MO), 20 ul/mL Phosphatase
Inhibitor Cocktail 2 (Sigma), 50 uM NaVO4). Protein containing
lysates were then cleared of cellular debris by centrifugation and
protein concentration was determined using a Bradford Protein
Assay (BioRad, Hercules, CA). SDS-PAGE was run on 50 mgo f
each sample on 12% polyacrylamide gels. Proteins were
transferred to Immobilon P membrane (Millipore, Billerica,
MA), the membranes were incubated with milk and then probed
with primary antibody. After removal of primary antibodies and
washing, membranes were incubated in the appropriate secondary
antibodies conjugated to horse-radish peroxidase. Washed blots
were incubated with chemiluminescence (ECL, Amersham)
reagents. Antibody reactivity was visualized by exposure of blots
to x-ray film. Some blots were stripped by incubation in 62.5 mM
Tris HCl pH 6.8 supplemented with 20 mM 2-mercaptoethanol
and 2% SDS, for 30 minutes at 50uC. The blots were then re-
probed with other antibodies including the JLA20 the anti-actin
antibody and E7 the anti tubulin antibody (both of these
antibodies were obtained from the Developmental Studies
Hybridoma Bank (University of Iowa).
Immunofluorescence labeling and imaging
Infected cells on coverslips were fixed with 2% paraformalde-
hyde and processed as described previously [25]. Incubation with
primary antibodies was performed in binding buffer supplemented
with 0.05% saponin. Coverslips were incubated with the
appropriate secondary antibodies into which the nucleic acid
dye 49,6-diamidino-2 phenylindole dihydrochloride (DAPI) had
been added. Coverslips were mounted on glass slides with
ProLong antifade (Molecular Probes). They were examined
through a 63X oil immersion lens on a Zeiss axiovert 200 M
integrated into a spinning disc confocal microscope technology
from PerkinElmer (Waltham, MA) controlled by the volocity
software. Z stack of optical sections spanning the entire cell were
captured and then combined using the extended focus feature in
the volocity software producing a 3D image.
Immuno-electron microscopy
Two methods of cell preparation were used. In the first, cells
infected for 72 H were fixed for 10 min at room temp then for 20
minutes at 4uC in a mixture of 4% formaldehyde and 1%
glutaraldehyde in 0.1 M cacodylate buffer (pH 7.2). The pellet,
embedded in low-gelling-point agarose to facilitate handling, was
dehydrated in an ethanol series, then embedded in LR White resin
(Electron Microscopy Science, Fort Washington, PA) and
polymerized at 50uC. Sections were cut with a diamond knife on
an RMC MT-6000-XL ultramicrotome and collected on For-
mvar-coated nickel grids. In the second method, 72 H-infected
cultures were scrapped into a small volume of 0.15 M sucrose in
RPMI. The cells were pelleted in 1.5 ml vials and they were
rapidly frozen in a Baltec HPM 010 high-pressure freezer
(Boeckeler Instruments, Tucson, AZ). Freeze-substitution was
carried out 5 days at 280uC in anhydrous acetone containing 2%
Leishmania Proteins Released in Infected Cells
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substitution medium was then increased from 290uCt o260uC
over 12 H, and the samples were washed with anhydrous acetone
three times at 260uC. Lowicryl HM20 (Electron Microscopy
Sciences) resin embedding was performed by a stepwise increase in
resin concentration from 0, 33, 66, to 100% over 48 H at 260uC.
The samples were then washed three times with 100% resin and
polymerized under UV light for 24 H at 260uC. Once completely
polymerized, the samples were slowly warmed from 260 to 20uC
over a 4 H period as described in [26]. Thick sections (80 to
approx. 120 nm thick) of Lowicryl HM20 embedded cells were
mounted on gold slot grids coated with formvar (Electron
Microscopy Sciences, Hatfield, PA). Grids were blocked with 1%
dry milk in phosphate-buffered saline (PBS, pH 7.2), treated
overnight at 4uC with primary antibody or normal mouse serum
(control) diluted 1:10 in PBS (chemically fixed samples) or 1:25
(cryofixed samples), washed with high salt Tris/Tween buffer
(0.5 M NaCl; 0.02 M Tris, pH 8.0; 0.1% Tween-20) and reacted
for 1 H with secondary antibody conjugated to 12 nm or 18 nm
gold (goat anti-mouse IgG; Jackson ImmunoResearch Laborato-
ries, West Grove, Pa.) diluted 1:30 in PBS. In experiments with
antisera to cTXNPx (Rat) a secondary antibody conjugated to
5 nm gold was used. Some sections were exposed to gold-labeled
secondary antibody alone as an additional control. After washing,
grids were floated on Trump’s fixative for 10 min and washed with
deionized water. Sections were then post-stained with 0.5% uranyl
acetate and lead citrate and were examined with a Zeiss EM-
10CA transmission electron microscope
Gold count
Immuno-EM labeling was performed as described. Images were
captured on Hitachi 700 TEM. Images were opened in ImageJ.
The area of the parasite, PV lumen, cytosol and nucleus were
measured and normalized using the measure bar on the image.
Gold particles were counted in each compartment and normalized
by dividing by the area of the compartment (mm
2). N=10.
Nuclear fractionation
RAW264.7 cells were cultured as described and infected with L.
pifanoi at ratio of 1:10. Cells were harvested at 48 and 72 H. Cells
were washed with cold PBS three times. They were then lysed in a
nuclear extraction buffer (10 mM Hepes, 10 mM KCl, 1% Triton
X 100, 0.1 mM Na3VO4, 2 mM MgCl2, 0.5 mM DTT, 1 mM
PMSF) and laid over 20% Ficoll-Paque (Pharmacia) as described
in [27]. The lysate was centrifuged at 13,000 rpm to separate the
cytoplasm from the nuclei. The supernatant was removed and
saved as crude cytosolic fraction. The nuclear pellet was washed 3
times using the nuclear extraction buffer. Aliquots of this fraction
that were monitored by light microscopy did not reveal the
presence of intact parasites. The nuclear pellet was then lysed in
RIPA buffer to release nuclear proteins. The Protein containing
lysates were then cleared of cellular debris by centrifugation and
protein concentration was determined using a Bradford Protein
Assay (BioRad, Hercules, CA). SDS-PAGE was run on 50 mgo f
each sample on 12% polyacrylamide gels. Proteins were
transferred to Immobilon P membrane (Millipore, Billerica, MA).
Results and Discussion
Generation of antiserum preferentially reactive to
Leishmania-infected cells
We elected to focus our studies on two Leishmania species: L.
mexicana pifanoi (MHOM/VE/57/LL1) a member of the L.
mexicana complex and L. donovani (MHOM/SD/62/1S-CL2).
The rationale for selecting these parasites included the following:
1) Experimental conditions for the transformation of these
parasites lines from the promastigote form to the amastigote form
and their maintenance as amastigotes is well established [22,28–
34]. Obtaining sufficiently adsorbed antibodies is a critical step in
the CMAT method, so it was important to have parasite lines with
stable growth in the amastigote stage under reproducible
conditions. 2) These two parasite species reside in morphologically
distinct PVs. L. pifanoi parasites reside in communal PVs that
undergo progressive distention over the length of the infection
period. In contrast, L. donovani parasites reside in tight PVs from
where daughter progeny segregate into new PVs. Since we did not
know which of these two intracellular environments would
represent a greater change in the parasite’s environment that
would induce differential gene expression, it was prudent to use
both parasites in our analyses.
To obtain serum that was preferentially reactive to infected
cells, lysates of RAW 264.7 macrophages infected for 24 H with
axenic amastigote forms of either Leishmania species were prepared
and used to immunize BALB/c mice. Immune serum was
collected and adsorbed extensively with whole amastigotes,
amastigote lysates, heat-killed amastigotes, and lysates of RAW
264.7 cells as described in the Materials and Methods section. The
resulting adsorbed serum had minimal reactivity with lysates from
axenic parasites, but retained reactivity to lysates from infected
cells. A representative ELISA showing the reactivity of pre-
adsorbed and adsorbed sera to axenic L. pifanoi (LL1) lysates and
infected cell lysate is shown in Figure 1. Even at a 1:50 dilution of
the adsorbed antisera, these sera had no reactivity to lysates
prepared from axenic parasites even though they retained their
reactivity to lysates prepared from infected cells. Similar results
were obtained with L. donovani reactive serum (not shown). This
implied that antibodies reactive to molecules expressed by axenic
parasites were depleted during the adsorption protocol. However,
the possibility that the adsorption of molecules expressed at low
levels by axenic parasites was incomplete cannot be ruled out. The
CMAT is an immunoscreen and its success is dependent on the
quality of the adsorbed immune serum as judged by its titer and
the diversity of the antigenic determinants to which the serum is
reactive. In the future, sera with more diverse immune reactivity
might be obtained by immunizing outbred mice species or rabbits.
Alternatively, pooled convalescence sera from human subjects
would provide a rich serum source with diverse antigenic
reactivity.
Isolation and identification of Leishmania molecules
The adsorbed immune sera were used to identify the new
antigenic parasite molecules that they were reactive to within
infected cells. To achieve this, these sera were used to screen
inducible expression libraries in E. coli BL21(DE3) cells containing
Leishmania genomic inserts from 0.5 to 2.0 Kbp cloned in
pET30abc (Novagen). The use of genomic expression libraries is
feasible in leishmaniasis because only a few parasite genes have
been shown to have introns. After a primary screen of 20,000
clones from the L. pifanoi library and 20,000 clones from the L.
donovani library, we obtained 27 clones reactive to the L. pifanoi
serum and 30 clones reactive to the L. donovani serum. Although
these library screens did not represent a total coverage of the
genome, we decided to proceed in order to evaluate the
characteristics of the molecules that were being identified by this
approach. Twenty total clones remained robustly positive after
tertiary screens. Four clones reactive to L. pifanoi and seven
reactive to L. donovani were randomly selected for further analyses.
The inserts in the clones were sequenced and the sequences were
Leishmania Proteins Released in Infected Cells
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Leishmania genomes in the sequence database www.genedb.org.
Table 1 shows the most likely homologs of the in vivo induced genes
(IVI) identified by CMAT. Six of the 10 IVI genes selected were
homologs of genes that encode hypothetical proteins for which the
Leishmania genes have no known homologs in organisms other than
kinetoplastids. Three of the remaining genes belonged to gene
families that encoded parasite molecules that had previously been
shown to be preferentially expressed in Leishmania amastigote
forms. The tryparedoxin peroxidase gene had been characterized
in promastigote and amastigote forms. There was only one
instance (IVI-7.1), in which we were not able to associate a gene
from the sequenced genomes to the sequence in the CMAT clone
even though a homologous sequence was found in the L. infantum
genome.
A concern with the selection of the parasite lines used in this
study was that genes in organisms such as L. pifanoi and L. donovani,
whose genomes had not been completely sequenced, might not
have homologs in the genomes that had been sequenced. This
concern was somewhat mitigated by the study in which
comparison of a few selected open reading frames (ORFs) of L.
mexicana were found to have a 89.5% identity to L. major ORFs
[35]. However, a study by Peacock and colleagues [36], in which
the genomes of L. braziliensis, L. infantum and L. major were
compared, identified 78 genes that are restricted to either genome
and observed an additional 200 sequence differences. Whether
any of such unique genes would have been detected in our screen
is unknown. With the exception of IVI-7.1 noted above, all the IVI
genes identified from the L. pifanoi and L. donovani expression
libraries were found to have homologs in the L. major, L. infantum
and L. braziliensis sequenced genomes. The sequence of the L.
mexicana and L. donovani genomes are now available.
Molecules identified by the CMAT screen
An intracellular variant of Typaredoxin peroxidase. The BLAST search
of the sequenced genomes with the IVI-16 sequence revealed that
this CMAT clone contained a L. pifanoi homolog of tryparedoxin
peroxidases (TXNPx). The clone contained the 39 region of the
Table 1. Leishmania effector molecules identified by CMAT.
Clone name Homologous Gene Indentified Chromosome Signal sequence Comment
IVI- 4 LmjF25.0450 LinJ25.0460 25 No Hypothetical protein, possibly GTP binding protein
IVI-14 LmjF04.1020 4 Hypothetical protein
IVI-16 LmjF15.1060 LmjF15.1140 LmjF15.1100 15 No Tryparedoxin peroxidase/peridoxins
IVI-18 LmjF30.2390 30 No Hypothetical protein serine peptidase with hemopexin
repeats
IVI- 3.1 LinJ08_V3.0400 LmjF08.0390 8 No Hypothetical protein
IVI-7.1 no predicted protein Sequence present in genome
IVI-7.2 LmjF10.1225 10 Hypothetical protein
IVI-59 LinJ31_V3.1500 LmjF31.1470 31 Yes Hypothetical protein
IVI-62 LmjF14.1440 LinJ07_V3.0470 14 No Cysteine proteinase
IVI-63 LinJ30_V3.1480 LmjF30.1420 30 No Ama 1
IVI-64 LmjF34.1080 LinJ34_V3.1150 34 No amastin-like surface protein
doi:10.1371/journal.pntd.0000842.t001
Figure 1. Adsorbed sera lose reactivity to axenically cultured parasites. Ninety six well plates were coated with lysates from axenically
cultured amastigotes (LL1 amastigotes) or lysates from macrophages infected with amastigotes for 24 H (infected macrophages 220C). ELISAs were
performed with two batches of sera before (Pre-adsorbed) and after (Adsorbed) adsorption. The optimal lysate concentrations used to coat the plates
as well as sera dilutions were first established. This figure is representative of several experiments to evaluate the reactivity of the absorbed serum.
Each data point is the average absorbance from triplicate wells.
doi:10.1371/journal.pntd.0000842.g001
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chromosome annotated as the developmentally regulated gene
(DRG). Induction of IVI-16 expression with IPTG produced a
15 kDa recombinant protein that included the c-terminus of the
TXNPx gene and vector sequences. A stop codon between the
TXNPx and DRG sequences prevented expression of the DRG
sequence in the clone. Using primers designed from the sequence
in the IVI-16 clone and the Leishmania splice leader, we obtained
the entire coding sequence of the gene in the CMAT clone by
amplification of cDNA prepared from L.pifanoi-infected cells. A
phylogentic analysis of the relatedness of this sequence with other
available TXNPx sequences showed that this gene is most closely
related to AAX47428, a gene from L. amazonensis, which like L.
pifanoi is a member of the L. mexicana complex (Figure S1). An
alignment of the predicted protein sequence of the new IVI-16
gene product with the available sequences of TXNPx in the
GeneDB genome database is shown in Figure 2. In addition to
amino acid sequence differences in the C-terminus of these
molecules, some TXNPx molecules including the IVI-16 gene
cloned here are nine amino acids shorter than other TXNPx
sequences. This is consistent with a previous study that
demonstrated the amastigote variant (P1) of L. chagasi peroxidoxin
is shorter by 9 amino acids than two other variants (P2 and P3)
preferentially expressed in L. chagasi promastigotes [37]. This
suggested that the gene identified by CMAT is amastigote specific.
This cloned variant of the L. pifanoi TXNPx gene is hereto forth
referred to as IVI-16/TXNPx. We also noted that there are
additional amino acid differences throughout the length of the
protein that might result in antigenic differences between this
protein and other TXNPx expressed by Leishmania parasites.
Tryparedoxin peroxidases (also called peroxidoxins or peroxir-
edoxins) belong to a gene family that has been characterized
extensively in Leishmania [37,38,39] and in other organisms as well
[40]. These molecules are antioxidants that detoxify peroxides,
hydroxyl radicals and peroxynitrite by several mechanisms
including oxidoreduction. These molecules are vital to the parasite
since it is believed that both in the insect vector and in the
mammalian host Leishmania encounter a range of toxic oxidative
environments that it must harness to survive. Moreover, recent
reports have implicated TXNPx in parasite dissemination and in
light of the inability to generate parasites that lack this gene, it was
suggested that TXNPx are necessary for parasite survival [38].
TXNPx variants have been described that localize to discrete
cellular compartments such as the mitochondrion and the cytosol
within the parasite [37,38]. As discussed above, the CMAT screen
resulted in the cloning of the L. pifanoi IVI-16/TXNPx. Given the
relatedness of the cloned gene to other TXNPx genes, it was
intriguing that antibodies to this molecule were not adsorbed out
after incubations with axenic parasite lysates. The possibility that
the adsorption protocol implemented was incomplete could not be
ruled out; alternatively, it was likely that the IVI-16/TXNPx
molecule identified is a variant that is antigenically different from
other TXNPx variants expressed in the parasite. Several pieces of
evidence support the latter statement. Western blot analysis of
lysates obtained from cultured organisms, as well as lysates from
infected cells and uninfected macrophages, probed with antiserum
raised with the IVI-16/TXNPx recombinant protein showed that
the antiserum was not reactive to lysates of uninfected macro-
phages (lane M) but exhibited strong and specific reactivity to a
molecule of ,20 kDa in lysates obtained from macrophages
Figure 2. Sequence comparison of IVI-16 with TXNPx gene sequences. The L. pifanoi IVI-16/TXNPx full length gene obtained by amplification
of cDNA from infected cells, was aligned with TXNPx genes from the GeneDB genome database using ClustalW.
doi:10.1371/journal.pntd.0000842.g002
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Promastigote stage parasites transform into the amastigote form in
10–24 H after entry into macrophages [41]. No comparable
reactivity was observed to lysates of cultured promastigotes alone
(P) or axenic amastigotes (A). The same lysates were tested for their
reactivity to P8 antiserum. P8 is a molecular complex that is
expressed in stationary stage promastigotes and axenic amastigotes
of L. pifanoi [42]. The complex was indeed identified within the
parasite lysates as well as within infected cells (Figure 3). The anti-
P8 antiserum was also non-reactive with lysates from uninfected
macrophages and actin levels in lysates from uninfected and
infected macrophages confirmed that the gel was loaded equally
(Figure 3). Northern blots probed with the IV1-16/TXNPx
sequence under stringent conditions revealed the presence of
transcripts of the endogenous IV1-16/TXNPx gene in axenic
promastigotes and amastigotes as well as infected cells, which is
consistent with reports of Leishmania genes being constitutively
transcribed (not shown).
Additional evidence that the IV1-16/TXNPx molecule identi-
fied by the CMAT screen is antigenically distinct from a cytosolic
variant of TXNPx (cTXNPx) expressed by these parasites was
obtained in protein depletion experiments. Here, lysates obtained
from infected macrophages were incubated with the anti-IVI-16/
TXNPx antiserum. The endogenous molecule in the lysate that is
reactive to this antiserum was depleted by adding protein G to the
lysate. The supernatant fluid from this depletion experiment was
then analyzed in Western blot assays for reactivity to the anti-IVI-
16/TXNPx antiserum and to an antiserum that is reactive to the
cTXNPx [39]. The incubation of infected cell lysates with the anti-
IVI-16/TXNPx depleted the endogenous molecules recognized by
Figure 3. Western blot analysis of the expression of the endogenous gene reactive with the antiserum to IVI-16/TXNPx. A. Lysates
were obtained from promastigotes cultures (P), axenic amastigotes (A), uninfected macrophages (M) and macrophages infected with promastigotes
for 24, 48 or 72 H. These were run on 12% PAGE and blotted onto nylon membranes. The membrane was probed with antiserum raised to the IVI-16/
TXNPx recombinant protein. The blot was stripped and probed with antibody to P8, which is a complex expressed by stationary stage promastigotes,
axenic amastigotes and infected cells. The blots were stripped again and probed with culture supernatant produced by the JLA20 hybridoma line. B.
Western blot of lysates from depletion experiments using IVI-16/TXNPx antiserum. Lysates from 48 and 72 H infections were incubating with 2 (IVI 1)
and 4 (IVI 2) ml of IVI-16/TXNPx antiserum or 2 (Tx1) or 4 (Tx2) ul of antiserum to cTXNPx (rat antibody). Protein G was added to deplete all molecules
reactive with the antisera. The remaining supernatant fluid was run on 15% PAGE and blotted. The blot was probed with the IVI-16/TXNPx antiserum,
stripped and re-probed with cTXNPx antiserum. This experiment was performed twice. [LC = light chain].
doi:10.1371/journal.pntd.0000842.g003
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antiserum to cTXNPx was not depleted (Figure 3B). Taken
together, these results show that IV1-16/TXNPx molecule, which
is expressed within infected cells, is antigenically different from the
cTXNPx that is also expressed in infected cells as well as by
axenically cultured organisms.
Other CMAT molecules
Six of the CMAT clones were homologs of genes annotated as
encoding hypothetical proteins in the sequenced genomes
(Table 1). This proportion of hypothetical proteins identified by
the CMAT screen should be expected since only a third of the
genes in the Leishmania genome have known homologs [43].
Application of sequence analyses tools on the homologs of the
genes that were identified revealed that two of these genes have
domains that might be suggestive of their function. The
LmjF25.0450 homolog identified by IVI-4 was found to contain
a GTP-binding domain, which suggests that this molecule might
play a role in signal transduction [44]. An NCBI PSI-blast of the
LmjF30.2390 gene identified by IVI-18 revealed that in addition
to its relatedness to serine peptidases, it contains both a leucine
rich repeat region (LRR) and hemopexin repeats. Over 100
proteins in L. major have been estimated to contain LRR
sequences, which mediate protein-protein interactions. Another
member of the LRR superfamily, LinJ34.0570, was recently
described and implicated in antimony resistance [45]. Hemopexin
repeats in proteins have been shown to mediate interactions with
heme [46]. This is of relevance to Leishmania biology since it has
been shown previously that Leishmania infections modulate heme
degradation in infected cells, which controls the capacity of the
infected cell to elaborate responses such as superoxide production
that are dependent on heme availability [25]. It is also of interest
that a molecule with heme binding activity was recently described
on the surface of L. infantum amastigotes [47]. Future studies on
these molecules should be illuminating.
Antisera were generated to the recombinant molecules encoded
by the original library clones in pET30. The antisera were first
confirmed for their reactivity to the recombinant antigens (not
shown) before they were used to detect the endogenous molecules
expressed in infected cells by Western blot assays, in immunoflu-
orescence assays and immune-electron microscopy. Only antisera
raised to the recombinant products of IVI-4, IVI-18 and IVI-59,
which are the homologs of LmjF25.0450, LmjF30.2390 and
LinJ31_V3.1500 respectively, reacted robustly to cells infected for
24 to 72 H. These antisera were reactive to infections with either
the L. pifanoi or L. donovani parasite lines used to initiate the studies.
Consequently, only analyses performed on L. pifanoi infected cells
are presented. The antiserum to IVI-4 was poorly reactive in
Western blot assays but exhibited specific reactivity to a parasite
structure within infected cells (see below). Representative Western
blot analyses to evaluate the expression of the endogenous genes
identified by IVI-18 and IVI-59 are shown in Figure 4. In
Figure 4A the reactivity of antiserum to IVI-18 is shown. This
antiserum was not reactive to lysates of uninfected macrophages
(lane M). In lysates prepared from macrophages infected for 24 to
72 H, a doublet of ,95 kDa is recognized by this antiserum. In
contrast, no molecule of comparable molecular weight is
recognized in lysates prepared from stationary promastigote
cultures or lysates from axenic amastigotes. In Figure 4B, the
reactivity of the antiserum to IVI-59 is shown. This antiserum too
was not reactive to lysates from uninfected macrophages (lane M).
The IVI-59 antiserum was reactive to a molecule in infected cells
of ,125 kDa. Other bands in infected samples were most likely
the result of protein degradation since the intensity of these bands
varied with each lysate preparation. This antiserum had limited
and inconsistent reactivity to lysates from axenic amastigotes and
lysates obtained from stationary stage promastigotes. Moreover,
any reactivity that was observed to promastigote or amastigote
preparations was at a higher molecular weight. Together these
results show that the L. pifanoi homolog of LmjF30.2390 and
LinJ31_V3.1500 are preferentially expressed within infected cells.
The apparent reduction in the levels of the endogenous proteins at
the 72 H point was most likely due to the loss of infected cells that
detach easily from the culture dish.
The three remaining molecules that were identified by the
library screens were found to be homologs of previously annotated
genes in the sequenced genomes. IVI-64 had similarity to
amastins, which are a family of proteins that have been shown
to be differentially expressed in Leishmania parasites [48,49].
Alignment of the IVI- 64 sequence with sequences of amastin
genes showed that it had highest similarity to LmjF34.1080 (Figure
S2), which is an amastin variant predicted to be expressed on the
parasite surface of amastigotes forms [46]. Knowledge of the
conditions that result in the differential expression of individual
members of the amastin gene family is incomplete. However, it has
been shown that amastins gene expression, analyzed at the mRNA
level, is regulated by the pH of their environment and that the
highest accumulation of amastins is evident after 5–7 days of
amastigote culture [48,49]. It is likely that similar to the situation
with IVI-16/TXNPx, the immunization with lysates from infected
cells resulted in the generation of antisera to an antigenically
distinct variant of amastins that is preferentially expressed within
infected cells.
The IVI-63 had similarity to the am3 gene (encoding for Ama1
protein), which was previously identified from a differentially
expressed cDNA library and shown to be amastigote specific [50].
Although the time course of appearance of the endogenous protein
was not evaluated in that study, transgenic parasites with an
episomal copy of the gene, were shown to express this protein on
the surface of parasites within infected cells. Further observations
on this molecule are described below. Finally, BLAST of the
NCBI database with the IVI-62 sequence showed that it had 99%
similarity to the L. infantum cysteine proteinase b gene (AJ420286).
Alignments of the IVI-62 sequence with the sequence of other
cysteine proteinases (not shown) have provided additional evidence
that it is indeed a cysteine proteinase.
Localization of endogenous IVI molecules in infected
cells
Immunofluorescence assays and immuno-electron microscopic
analyses were performed to determine the distribution within
infected cells of the endogenous molecules that were identified by
the CMAT screen. The distribution of the endogenous IVI-16/
TXNPx molecule within infected cells was determined. The IVI-
16/TXNPx antiserum labeled the parasite within infected cells
(Figure 5, [thin white arrow points to a representative parasite]).
There was also labeling of the PV in regions where there were no
parasites. In addition, the antiserum labeled structures in the
cytosol outside the PV (thick white arrows). The pattern of labeling
of endogenous IVI-16/TXNPx was compared to the pattern of
labeling of previously described antisera to the cTXNPx [39] and
the mitochondrial TXNPx (mTXNPx) [38]. Both the antiserum to
cTXNPx and mTXNPx exhibited specific and restricted labeling
of the parasite within infected cells with patterns that were
consistent with cytoplasmic staining and mitochondrial staining
respectively; they did not label any structures outside the parasite.
To obtain greater resolution of the structures that were reactive
to the IVI-16/TXNPx antiserum, immuno-labeling of infected cell
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performed. Two protocols for sample preparation for EM analyses
were used. LR white embedding of chemically fixed cells
permitted better resolution of membranous structures as compared
to cryofixation of samples. However, all the antisera that were used
in this study labeled sections prepared with the latter protocol with
greater sensitivity. EM images using both of these protocols are
presented in Figure 6. In Figure 6A a representative example of
the pattern of labeling observed when the IVI-16/TXNPx
antiserum was applied on samples obtained by cryofixation is
shown. In these samples the antiserum labeled the parasite, the PV
lumen and the cell cytosol outside the PV (black arrows). The
pattern of labeling of consecutive sections with NMS was
ascertained for comparison. A representative image of a cell
Figure 4. Western blot analyses of the expression of the endogenous genes reactive to IVI-18 and IVI-59 antisera. Lysates obtained
from promastigotes cultures (P), axenic amastigotes (A), uninfected macrophages (M) and macrophage cultures infected for 24, 48 or 72 H were run
on 12% PAGE and blotted onto nylon membranes. A. A membrane was probed with the antiserum that was raised to IVI-18 recombinant fragment. B.
Another membrane was probed with antiserum that was raised to a recombinant fragment of IVI-59. The membranes were stripped and probed with
the anti-actin JLA20 monoclonal antibody. This experiment is representative of at least 4 similar experiments.
doi:10.1371/journal.pntd.0000842.g004
Figure 5. Immunolocalization of the endogenous IVI-16/TXNPx molecule, reactive with IVI-16/TXNPx antiserum. RAW 264.7
macrophages on coverslips were infected for 72 H and then fixed. Immunofluorescence staining was performed with antisera raised to the IVI-16/
TXNPx recombinant, and antisera to the mitochondrial TXNPx (mTXNPx) and cytoplasmic TXNPx (cTXNPx). LAMP-1(green label) reactivity identifies
lysosomes and delineates the PV membrane. DAPI (blue) labels nuclei. Specific reactivity by each antiserum is in red. The thin white arrows point to
representative parasites in PVs. The thick arrows points to regions of antibody reactivity outside the parasite. Covers slips that were incubated with
anti-cTXNPx were not assessed for LAMP-1 reactivity (re- both are rat antibodies). Secondary antibodies alone produced background reactivity. These
images captured with a Zeiss axiovert 200 M integrated into a spinning disc confocal microscope technology from PerkinElmer (Waltham, MA)
controlled by the volocity software. Z stack of optical sections spanning the entire cell were captured and then combined using the extended focus
feature in the volocity software producing a 3D image. Immunofluorescence assays are representative of more than 3 experiments with these
antisera.
doi:10.1371/journal.pntd.0000842.g005
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with immune serum is shown in Figure 6A (arrows in this image
point to gold particles). To quantify the proportion of gold labeling
that was attributable to the reactivity of the IVI-16/TXNPx
antiserum, gold particles in EM sections were enumerated.
Figure 6B shows that in sections incubated with the IVI-16/
TXNPx antiserum there were approximately33 gold particles/
mm
2 on the parasite, 2 particles/mm
2 in the PV lumen, 1 particle/
mm
2 in the cytosol and 3.5 particles/mm
2 in the nucleus. In
contrast, there were 1, 0.14, 0.35 and 1.65 gold particles/mm
2 on
Figure 6. Localization of the endogenous molecule reactive with IVI-16/TXNPx antiserum by Immuno-EM. A. Cryofixed samples
embedded in Lowicryl HM20 and sectioned were incubated with antiserum to IVI-16/TXNPx. This was followed by incubation with an anti-mouse
18 nm-gold conjugated antibody. Consecutive sections were incubated with normal mouse serum (NMS). Arrows in Figure show gold particles. B.
Gold particles on sections incubated with either the antiserum to IVI-16/TXNPx or NMS were enumerated and the data was plotted. At least 10 cells
were counted per experiment. The difference between counts from the specific antiserum and NMS were assessed in a t-test. Asterix denote
significant difference, P,0.5. C. Infected cells were chemically fixed then embedded in LR White resin. Sections mounted on nickel grids were
incubated with the antiserum to IVI-16/TXNPx followed by incubation with an anti-mouse 15 nm-gold conjugated antibody. Thin black arrow points
to gold particles on the parasite; bold white arrows point to gold particles in the host cell. D. Double labeling experiment; samples from cryofixation
were incubated with antiserum to IVI-16/TXNPx (mouse) as well as the antiserum to cTXNPx (rat). The reactivity of cTXNPx was monitored with an
anti-rat 5 nm gold conjugated secondary antibody. Thin black arrows point to examples of 5 nm gold; thick black arrows point to examples of 18 nm
gold. E. Gold particles in double labeling experiments were enumerated and plotted. Asterix denote significant difference, P,0.05. Legend:
M=macrophage; P=Parasite; N=Nucleus.
doi:10.1371/journal.pntd.0000842.g006
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applied on these sections. With the exception of the nucleus, the
difference between the concentration of gold particles in within
cellular compartments of sections incubated with IVI-16/TXNPx
antiserum was significantly (p,0.05 t-test) higher than for particles
on sections incubated with NMS. Analysis of samples processed
after fixation and LR white embedding also showed that the IVI-
16/TXNPx antiserum labeled the parasite with a pattern that is
best described as cytosolic. In addition, there was evidence of
labeling of the PV lumen and vesicles in the cell cytosol outside the
PV (Figure 6C) [white arrows point to gold particles and vesicular
structures]. The vesicular structures in the cytosol, (some of which
are labeled) had a ‘fuzzy’ coat that is reminiscent of coated vesicles.
Labeling of such vesicles was observed only with the antiserum to
IVI-16/TXNPx. The pattern of labeling of uninfected cells with
this antiserum was similar to the pattern of labeling of infected cells
with normal mouse serum (NMS).
To address the possibility that the observed labeling in the PV
and the infected cell cytosol might be derived from dead parasites,
fresh grids containing sections of infected cells were double labeled
with the antiserum to the cTXNPx and IVI-16/TXNPx
antiserum. A representative image showing the pattern of a
Figure 7. Immunolocalization of the endogenous molecules that are reactive to antisera to IVI-4, IVI-18 and IVI-59. RAW 264.7
macrophages on coverslips were infected for 72 H and then fixed. Immunofluorescence staining was performed with antisera raised to recombinant
IVI-4, IVI-18 and IVI-59.
doi:10.1371/journal.pntd.0000842.g007
Leishmania Proteins Released in Infected Cells
www.plosntds.org 12 October 2010 | Volume 4 | Issue 10 | e842Figure 8. Localization of the endogenous molecule reactive with IVI-59 antiserum by Immuno-EM. A. Infected cells were fixed then
embedded in LR white resin. Sections on nickel grids were incubated with the antiserum to IVI-59. This was followed by incubation with an anti-
mouse 15 nm-gold conjugated antibody. Labeling of parasites in an infected cell is shown. Highlighted area was blown up to show gold labeling on
the parasite surface as well as in the host cell nucleus (thin black arrows point to examples of a few gold particles. The highlighted area was zoomed
in to show labeling of the parasite surface and labeling of the host cell nucleus; gold particles were also found in‘empty vesicles’ in the cell cytosol.B .
Cryofixed samples embedded in Lowicryl HM20 and sectioned were incubated with antiserum to IVI-59. This was followed by incubation with an anti-
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cTXNPx was visualized with 5 nm gold particles [thin arrows].
The cTXNPx antiserum resulted in robust labeling of the parasite
forming a pattern of labeling that is consistent with a cytoplasmic
distribution of the endogenous molecule. The antibody to
cTXNPx exhibited minimal reactivity outside the parasite.
Labeling with the IVI-16/TXNPx antiserum also resulted in a
pattern on the parasite that was consistent with a cytoplasmic
distribution pattern. However, it is evident that the IVI-16/
TXNPx antiserum labels structures in the PV lumen outside the
parasite as well as the host cell cytosol (thick black arrows). Gold
particles from such double labeling experiments were enumerated
(Figure 6E). There were significantly fewer 5 nm gold particles
(cTXNPx) in the PV lumen, the host cell cytosol and nucleus as
compared to large gold particles (IVI-16/TXNPx). A surprising
observation, however, was that there was less 18 nm gold and
5 nm gold labeling on the parasites in the double labeling
experiments than what was observed in the single labeling
experiments. This suggested that both antibodies competed for
antibody binding sites but only on molecules that were expressed
within the parasite. Nonetheless, these results provide additional
evidence that the endogenous IVI-16/TXNPx variant is antigen-
ically different from the cytosolic variant previously described.
Furthermore, the endogenous IVI-TXNPx molecule appears to
traffic out of the parasite into the PV and beyond the PV into the
host cell cytosol in coated vesicles. The double labeling
experiments argue against the likelihood that labeling in the PV
lumen and within the infected cell cytosol was derived from dead
parasite material.
The distribution of the endogenous molecules that are reactive
to antisera to IVI-18 and IVI-59 was also investigated in parallel
experiments. Recall that these antisera too were raised to
recombinant molecules and that they exhibited no reactivity to
macrophage molecules in non-infected cells. Immunofluorescence
assays of infected cells with antiserum to IVI-59 showed that this
molecule labeled the parasites within PVs (thin white arrow points
to representative parasite) (Figure 7). In addition, there was
labeling of the PV lumen, PV membrane and structures in the host
cell cytosol (bold white arrows). We proceeded to perform
immuno-EM analysis to assess further, the reactivity of the IVI-
59 antiserum. Sections obtained by LR white embedding of
chemically fixed cells showed that the endogenous molecule
identified by this antiserum is localized primarily to the parasite
surface (Figure 8A [arrows point to examples of gold particles).
Unlike the observation made with antiserum to IVI-16/TXNPx
that labeled what appeared to be coated vesicles in the host cell
cytosol, the IVI-59 antiserum labeled vesicles of various sizes that
had no other distinguishing characteristics in the host cell cytosol.
We next analyzed sections that were processed after cryofixation.
The distribution pattern of the IVI-59 molecule on the parasite
was as observed in the chemically fixed and LR White embedded
sections. Additional observations were made with the cryofixed
samples. One of the more intriguing observations was the presence
of gold particles in membrane enclosed compartments within the
parasite and also on vesicular structures on the parasite surface
(Figure 8B [thin black arrows]). The labeled vesicular structures on
the parasite surface appeared to have ‘bubbled’ from the parasite
These vesicular structures on the parasite surface are reminiscent
of exosomes recently described by Silverman and colleagues [51].
However, these vesicles did not appear to have been released from
the flagellar pocket. Another interesting observation with this
antiserum was the apparent transfer of the endogenous IVI-59
molecule from parasites in the PV to host cell vesicles (Figure 8C
[blue arrows point to gold particles on the parasite surface, at the
parasite-macrophage interface and in vesicular structures within
the host cell]). The recipient vesicle in the host cytosol had similar
characteristics to other vesicles of various sizes with no other
outstanding characteristics that were labeled with gold particles in
the host cell cytosol. Finally, immuno-labeling of these sections
also exhibited reactivity of the host cell nucleus. Gold particles on
the parasite, the PV lumen, the host cell cytosol and the host cell
nucleus were enumerated and compared to the distribution of gold
particles on sections that were incubated with NMS. Figure 8D
shows that there was significantly more gold particles in all the
compartments analyzed when the sections were incubated with the
antiserum to IVI-59. Double labeling experiments with the IVI-59
antiserum and the antiserum to cTXNPx were also performed; a
representative image of a double labeled cell is shown in Figure 8E.
The cTXNPx exhibits robust labeling of the parasite (black
arrows). In contrast the IVI-59 antiserum primarily labels the
parasite surface (bold white arrows). The concentration of gold
particles on these sections was determined and plotted (figure 8F).
There was considerable labeling of the parasite by the antiserum to
cTXNPx but minimal reactivity elsewhere. Interestingly there was
no apparent interference between the cTXNPx labeling and the
labeling with the IVI-59 antiserum as was noted with the IVI-16/
TXNPx antiserum. Taken together, analysis of the distribution of
the endogenous molecule (homolog of LinJ31_V3.1500) that is
reactive with IVI-59 antiserum showed that this molecule is
expressed primarily on the parasite surface. However, it is released
into infected cells and traffics outside of the PV to the host cell
nucleus. Here too, the double labeling experiments suggested that
the extra-parasite labeling of the IVI-59 antiserum is unlikely to be
the result of trafficking of molecules from dead parasites.
The distribution of the IVI-18 molecules was also analyzed in
parallel experiments. Figure 7 shows a representative image of an
infected cell captured after immunofluorescence staining with
antiserum to IVI-18. There is specific staining of parasites within
infected cells. We proceeded to analyze samples processed for
immuno-EM analyses. There was no difference of interest between
samples processed by the chemical fixation and LR white
embedding protocol and the cryofixed samples. A representative
image from cryofixed samples shows the distribution pattern of the
endogenous molecule recognized by the IVI-18 antiserum
(Figure 9A [black arrows point out representative gold particles]).
This molecule appears to be expressed primarily on the parasite
surface. Gold particles on the parasite, PV lumen, host cell cytosol
and host cell nucleus were enumerated and plotted. When sections
were incubated with the IVI-18 antiserum, the number of gold
particles on parasites was significantly higher than that obtained
mouse 18 nm-gold conjugated antibody. Gold labeling of a parasite in a PV is shown. Arrows point to gold articles in membrane bound structures
within the parasite and in vesicular structures on the surface of the parasite in zoomed in images. C. A parasite in a PV is shown; blue arrows point to
gold labeling on the parasite surface; labeling at the PV-host cell interface and gold particles in the host cell cytosol. D. Gold particles on sections
incubated with either the IVI-59 antiserum or NMS were enumerated and plotted. At least 10 cells were counted per experiment. E. Double labeling
experiments; cryofixed samples were incubated with antiserum to IVI-59 (mouse) as well as the antiserum to cTXNPx (rat). The reactivity of cTXNPx
was monitored with an anti-rat 5 nm gold conjugated secondary antibody. Thin black arrows point to examples of 5 nm gold; thick black arrows
point to examples of 18 nm gold. F. Gold particles in double labeling experiments were enumerated and plotted. Asterix denote significant
difference, P,0.5. Legend: M=macrophage; P=Parasite; N=Nucleus.
doi:10.1371/journal.pntd.0000842.g008
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Lowicryl HM20 and sectioned were incubated with antiserum to IVI-18. This was followed by incubation with an anti-mouse 18 nm-gold conjugated
antibody. Gold labeling of a parasite in a PV is shown. Arrows point to gold particles on the parasite surface. B. Gold particles on sections incubated
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more gold particles in the other compartments analyzed as
compared to incubation with NMS. It is noteworthy that the
overall concentration of gold particles in sections incubated with the
IVI-18 antiserum was less than what was obtained with the IVI-59
antiserum, for example. Taken together, these observations too
show that the homolog of LmjF30.2390 that is recognized by the
antiserum to IVI-18 is primarily localized to the parasite surface but
that it also gains access to the host cell cytosol and nucleus.
The reactivity of the antiserum raised to the IVI-4 was unique
as compared to the other CMAT molecules. Although there was
strong reactivity to parasites within PVs there was minimal
reactivity of this antiserum elsewhere in the infected cell (Figure 7).
This suggested that the homolog of LmjF25.0450 identified by
IVI-4 is neither released into the PV nor secreted into the host cell
cytosol. Representative confocal images of the reactivity of antisera
to IVI-62, IVI-63 and IVI- 64 are included in the supplemental
figures (Figure S3). Both IVI-63 and IVI- 64 appear to be localized
to the surface of parasites within PVs. These observations confirm
previous reports that had shown that the AMA molecule (homolog
of IVI-63) and some amastin variants (IVI-64) are expressed on the
parasite’s surface [49]. Table 2 shows a summary of the
distribution of the endogenous molecules identified in this study.
Nuclear localization of exported IVI molecules
The localization studies of the endogenous IVI molecules
described above suggested that some of those parasite molecules
might traffic to the host cell nucleus. To determine whether
endogenous IVI molecules are localized in the nucleus of infected
cells, a subcellular fractionation protocol to isolate the nucleus of
infected cells was implemented. The resulting nuclear and
cytosolic fractions were analyzed by Western blot analysis for
their reactivity with antisera to IVI-16/TXNPx, IVI-18 and IVI-
59. After 48 and 72 H infections, the IVI-16/TXNPx antiserum is
exclusively reactive with the cytosolic fraction (Figure 10).
Similarly, the antiserum to IVI-18 is mostly reactive with the
cytosolic fraction with occasional faint reactivity with the nuclear
fraction. In contrast, the IVI-59 antiserum is reactive with both the
nuclear and cytosolic fractions. Its reactivity with the nuclear
fraction is with a molecule that is at the appropriate molecular
weight. The quality of the subcellular fractionation was monitored
with the reactivity of DE6, an antibody that is specific for a 47/
51 kDa nucleolar protein [52]. Taken together, these observations
complement the results obtained by counting gold particles on EM
sections that had found that the labeling of the nucleus with the
IVI-59 antiserum was significantly more than that obtained with
NMS. In contrast although there was more gold labeling of the
host nucleus with antisera to IVI-16/TXNPx and IVI-18, the
difference was not significantly different from the labeling with
NMS. An important caveat in the interpretation of these results
though is that the subcellular fractionation protocol as imple-
mented was stringent and could therefore exclude some molecules
that traffic to the nucleus under physiological conditions.
Prior to the observation reported here of Leishmania parasite
molecules trafficking in the infected cell, elongation factor 1a (EF-
1a) from Leishmania had been shown to localize to the host cell
cytosol where it targets SHP-1 [53,54]. EF-1a was identified within
macrophages after 16 hours of infection by promastigotes, however
the mechanism by which EF-1a accesses the host cell cytoplasm has
not been described. Several lines of evidence have also suggested
that cysteine proteinases too, must gain access to the infected cell
cytosol where they target components of the NFkB signaling
complex [55]. This led Mottram and colleagues to propose that
cysteine proteinases are most likely transported out of the PV in
vesicles which rupture in the cytosol [56]. In this study, IVI-62 (a
cysteine proteinase homolog) was identified by the CMAT screen
and found to gain access to the cell cytosol. In addition to IVI-62,
several lines of evidence were obtained that showed that other
Leishmania parasite molecules are released beyond the PV as well.
It is noteworthy that the presence or absence of a signal
sequence was not predictive of the trafficking scheme of parasite
molecules in the infected cell. This observation is in agreement
with a recent study in which parasites molecules that are secreted
into culture medium (secretome) were analyzed [57]; in that study,
it was concluded that most of the molecules identified did not
appear to be secreted through the classical secretion pathway. The
authors discussed that Leishmania might possess several secretion
pathways in addition to secretion through the flagellar pocket. In
this study, the vesicular structures that were reactive with the IVI-
59 antiserum might be a part of one of those secretion pathways.
Further studies employing reagents to the parasite molecules
identified in this study should provide greater insight into protein
secretion by Leishmania parasites within infected cells.
The protein products of the CMAT genes analyzed thus far
were detected in infected cells after many hours (days) of infection,
however, their transcripts were detected in parasites that were
cultured axenically (not shown). Studies on LIT1, the ZIP family
iron transporter had also found that although the transcripts of
Table 2. Cellular location of CMAT molecules.*
Molecule (clone) PV Host cell cytosol Host cell nucleus
IVI-4 2/+ (punctuate labeling of parasite) - -
IVI-16/aTXNPx ++ + (fuzzy vesicle) +/2
IVI-18 ++ (‘empty vesicles’) +
IVI-59 + (strong parasite surface labeling) + (‘empty vesicles’) ++ (localization to peripheral heterochromatin)
IVI-62 (cysteine proteinase) ++ + + /2
IVI-64 (amastin-like surface protein) + (parasite surface labeling ++ + (localization to heterochromatin, not in
nuclear periphery)
*Data was obtained from analyses of IFA’s and immuno-EM.
doi:10.1371/journal.pntd.0000842.t002
with either the IVI-18 antiserum or NMS were enumerated and plotted. At least 10 cells were counted per experiment. The difference between counts
from the specific antiserum and NMS were assessed in a t-test. Asterix denote significant difference, P,0.5.
doi:10.1371/journal.pntd.0000842.g009
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protein product is detected only in parasites within PVs after
several days of infection [12]. Together, these observations suggest
that of the estimated 8300 Leishmania proteins there is a subset of
genes for which the protein products are synthesized only in the
intracellular environment. This subset might also include parasite
molecules that are preferentially expressed at discrete times in the
infected host. It is not known how many molecules would fall into
this subset. Such molecules are of great interest because they might
mediate the pathogenic mechanisms of the parasite and represent
biomarkers of disease progression in the infected host.
CMAT, like IVIAT, has limitations that should be acknowl-
edged. It is an immunoscreen so only molecules that are
immunogenic will be identified; this implies that molecules that
undergo lipid or carbohydrate modifications in response to the
environmental changes in the PV may not be detected by these
methods. In addition, genetic control of immune reactivity can
limit the diversity of epitopes that are generated in a given host.
The later limitation can be minimized by using outbred animals
(hamsters and rabbits) for the generation of antisera; alternatively,
pooled human convalescence sera can be obtained. The
expression library constructed in pET expression vectors might
not be fully representative as it relies on the availability of Sau3A
sites which might not be in the proximity of some genes. Lastly, as
implemented here, the approach is dependent on significant
difference in gene expression between axenically cultured parasites
and parasites that grow within cells.
There might be some benefit to using established parasite lines
or parasite lines that have undergone multiple passages in axenic
culture as was done in this CMAT approach. The rationale that is
often stated for using parasites soon after they are recovered from
the in vivo environment is that they might still be expressing in vivo
induced pathogenic molecules. How soon the expression of such
molecules is suppressed is however not known. If parasites that
were recently established in culture were used in CMAT, the
continued presence of in vivo expressed molecules might result in
the removal of antibodies that are reactive to them during the
adsorption protocol. Since it is not known which molecules have
primary functions in the intracellular environment, it would be
impossible to determine what has been lost.
Supporting Information
Figure S1 The phylogenetic relationship between the TXNPxs.
The phylogenetic relationship between the TXNPxs was inferred
using the Neighbor-Joining method. The percentage of replicate
Figure 10. Localization of IVI molecules in nuclear and cytosolic fractions of infected cells. Macrophages infected for 48 or 72 H were
recovered cytosolic and nuclear fractions were prepared. Equal protein aliquots of the total lysate (T) and each fraction was run on 12% PAGE and
blotted. Identical blots were probed with antisera to IVI-16/TXNPx, IVI-18 or IVI-59. The blots were stripped and probed with DE6, which reacts to a
nucleolar protein. The region of each gel with the expected bands was cropped and combined to make the composite figure. This experiment was
run twice.
doi:10.1371/journal.pntd.0000842.g010
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bootstrap test (1000 replicates) are shown next to the branches.
The tree is drawn to scale, with branch lengths in the same units as
those of the evolutionary distances used to infer the phylogenetic
tree. The evolutionary distances were computed using the Poisson
correction method and are in the units of the number of amino
acid substitutions per site. All positions containing gaps and
missing data were eliminated from the dataset (complete deletion
option). There was a total of 175 positions in the final dataset.
Phylogenetic analyses were conducted in MEGA4.
Found at: doi:10.1371/journal.pntd.0000842.s001 (0.50 MB TIF)
Figure S2 Sequence comparison of the CMAT clone 64
sequence with amastin-like sequences in the GeneDB genome
database and phylogenetic analysis. The sequence in CMAT clone
64 was aligned with genes in the GeneDB genome containing
amastin-like sequences. B) The phylogenetic relationship was
inferred using the Neighbor-Joining method [58]. The percentage
of replicate trees in which the associated taxa clustered together in
the bootstrap test (1000 replicates) are shown next to the branches.
The tree is drawn to scale, with branch lengths in the same units as
those of the evolutionary distances used to infer the phylogenetic
tree. The evolutionary distances were computed using the Poisson
correction method and are in the units of the number of amino
acid substitutions per site. All positions containing gaps and
missing data were eliminated from the dataset (complete deletion
option). There was a total of 101 positions in the final dataset.
Phylogenetic analyses were conducted in MEGA4 [59].
Found at: doi:10.1371/journal.pntd.0000842.s002 (1.74 MB TIF)
Figure S3 Immunolocalization of native molecules identified by
CMAT in infected cells. RAW 264.7 macrophages on coverslips
were infected for 72 hours and then fixed. Immunofluorescence
staining was performed with antisera raised to recombinant IVI
molecules shown. LAMP1(green label) reactivity identifies lyso-
somes and delineates the PV membrane. Specific reactivity by
each antiserum is in red. The thin arrow points to a representative
parasite in a PV. The thick arrow points to an example reactivity
outside PVs. These images were captured with a Zeiss confocal
microscope integrated into a spinning disc technology system from
PerkinElmer; Z stack series were combined with the extended
focus feature in the velocity software. Immunofluorescence assays
are representative of more than 3 experiments with these antisera.
Found at: doi:10.1371/journal.pntd.0000842.s003 (2.38 MB TIF)
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